|
octa |
18 |
|
glaucoma |
14 |
|
hong kong |
14 |
|
cataract |
12 |
|
ocular surface disease |
12 |
|
chinese |
11 |
|
epidemiology |
11 |
|
exophthalmometry values |
11 |
|
hertel's |
11 |
|
macular vascular density |
11 |
|
macular vessel density |
11 |
|
optical coherence tomography angiography |
11 |
|
prevalence |
11 |
|
proptosis |
11 |
|
visual impairment |
11 |
|
eye diseases |
9 |
|
asians |
8 |
|
intraocular pressure |
8 |
|
severe cutaneous adverse reactions |
8 |
|
stevens–johnson syndrome |
8 |
|
toxic epidermal necrolysis |
8 |
|
macular microcirculation |
7 |
|
mental health |
7 |
|
neuroprotection |
7 |
|
obesity |
7 |
|
ocular perfusion |
7 |
|
physical exercise |
7 |
|
vessel density |
7 |
|
anti-vegf |
6 |
|
bevacizumab |
6 |
|
bleb leak |
6 |
|
cystic bleb |
6 |
|
pterygium |
6 |
|
ranibizumab |
6 |
|
age-related macular degeneration |
5 |
|
awareness |
5 |
|
collagen crosslinking |
5 |
|
conjunctival leak |
5 |
|
drop instillation |
5 |
|
dry eye |
5 |
|
dry eye disease |
5 |
|
knowledge |
5 |
|
meibomian gland dysfunction |
5 |
|
menorrhagia |
5 |
|
ocular surface disease index |
5 |
|
patients |
5 |
|
public health |
5 |
|
reperfusion injury |
5 |
|
rheumatoid arthritis |
5 |
|
risk factors |
5 |
|
sjogren syndrome |
5 |
|
survey |
5 |
|
tear osmolarity |
5 |
|
vascular factors |
5 |
|
visual field |
5 |
|
consensual ophthalmotonic reaction |
4 |
|
express shunt |
4 |
|
filtering surgery |
4 |
|
glaucoma surgery |
4 |
|
hyperopia |
4 |
|
meta-analysis |
4 |
|
myopia |
4 |
|
open angle glaucoma |
4 |
|
paediatric ophthalmology |
4 |
|
refractive error |
4 |
|
selective laser trabeculoplasty |
4 |
|
systematic review |
4 |
|
trabeculectomy |
4 |
|
argon laser peripheral iridoplasty |
3 |
|
bullous keratopathy |
3 |
|
cataract extraction |
3 |
|
childhood glaucoma |
3 |
|
collagen cross-linking |
3 |
|
corneal decompensation |
3 |
|
corneal edema |
3 |
|
corneal thickness |
3 |
|
crosslinking |
3 |
|
cyclodiode |
3 |
|
demyelinating disease |
3 |
|
express mini-shunt |
3 |
|
filtering bleb |
3 |
|
glaucoma drainage devices |
3 |
|
glaucoma implants |
3 |
|
goniotomy |
3 |
|
neuroophthalmology |
3 |
|
optic neuritis |
3 |
|
pediatric glaucoma |
3 |
|
pediatric glaucoma surgery |
3 |
|
phacotrabeculectomy |
3 |
|
plateau iris configuration |
3 |
|
plateau iris syndrome |
3 |
|
primary angle-closure glaucoma |
3 |
|
primary congenital glaucoma |
3 |
|
recurrent acute angle-closure attack |
3 |
|
rubeotic glaucoma |
3 |
|
steroid-induced glaucoma |
3 |
|
surgery |
3 |
|
trabeculotomy |
3 |
|
tube shunts |
3 |
|
0.01% atropine |
2 |
|
administration, topical |
2 |
|
anti-bacterial agents - administration & dosage |
2 |
|
antifungal agents - administration & dosage |
2 |
|
biomechanical properties |
2 |
|
combined treatment |
2 |
|
conjunctiva |
2 |
|
contact lenses - microbiology |
2 |
|
covalent bond |
2 |
|
covid-19 |
2 |
|
disease outbreaks |
2 |
|
fusarium |
2 |
|
hong kong - epidemiology |
2 |
|
humans |
2 |
|
iris |
2 |
|
keratitis - epidemiology - microbiology |
2 |
|
membranes |
2 |
|
mycoses - drug therapy |
2 |
|
myopia control |
2 |
|
orthokeratology |
2 |
|
phacoemulsification |
2 |
|
pupillary membrane |
2 |
|
riboflavin |
2 |
|
teleglaucoma |
2 |
|
telemedicine |
2 |
|
treatment outcome |
2 |
|
angle-closure |
1 |
|
antimicrobial susceptibility |
1 |
|
congenital nasolacrimal duct obstruction |
1 |
|
corneal biomechanics |
1 |
|
glaucoma: mental health |
1 |
|
hypertensive glaucoma |
1 |
|
infant |
1 |
|
lacrimal sac |
1 |
|
levofloxacin |
1 |
|
meditation |
1 |
|
methicillin-resistant staphylococcus aureus |
1 |
|
microbiology |
1 |
|
multidrug resistance |
1 |
|
normal tension glaucoma |
1 |
|
ocular infection |
1 |
|
pattern scanning laser |
1 |
|
pediatrics |
1 |
|
peripheral iridotomy |
1 |
|
primary angle-closure suspect |
1 |
|
primary open-angle glaucoma |
1 |
|
psychological |
1 |
|
quality of life |
1 |
|
sequential laser peripheral iridotomy |
1 |
|
staphylococcus aureus |
1 |
|
surgical outcome |
1 |
